Erasca, Inc. SEC filings ERAS
Erasca, Inc. has 352 filings in SEC EDGAR's recent list, going back to Jan 15, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2025 | — |
| EFFECT | Filing | May 16, 2024 | — |
| CORRESP | Letter to the SEC | May 14, 2024 | — |
| UPLOAD | Letter from the SEC | May 14, 2024 | — |
| EFFECT | Filing | Aug 18, 2022 | — |
| CORRESP | Letter to the SEC | Aug 16, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2022 | — |
| EFFECT | Filing | Jul 15, 2021 | — |
| CERT | Filing | Jul 15, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 13, 2021 | — |
| 8-A12B | Filing | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 12, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 28, 2021 | — |
| CORRESP | Letter to the SEC | Jun 25, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2021 | — |
| DRSLTR | Filing | Jun 9, 2021 | — |
| DRS/A | Filing | Jun 9, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2021 | — |
| DRS | Filing | May 7, 2021 | — |
| D | Filing | Apr 30, 2020 | — |
| D/A | Filing | Mar 11, 2019 | — |
| D | Filing | Jan 15, 2019 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ERAS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1761918
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.